(3) outcomes: all clinical outcomes, such as cardiovascular event, death, changing in glycosylated hemoglobin type A1C (HbA1c), body weight, fasting plasma glucose (FPG) and safety outcomes
Chapter 13 Exploration of biotechnological studies in low-calorie sweetener Stevia rebaudiana : present and future prospects, in Medicinal and Aromatic Plants: Expanding Their Horizons Through Omics
4648 Mechanistically, TMAO may induce T2DM by inducing pancreatic -cell dysfunction, chronic inflammation, oxidative stress, and disrupting glucose and lipid homeostasis
This may support nutrient and oxygen supply to reproductive tissues
The page is built around patient education and clinical context, with the highest-value checks sitting around the main claim, safety boundary, and next practical step